Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Orasure Tech Inc (OSUR)

Orasure Tech Inc (OSUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Orasure Tech Inc 220 EAST FIRST STREET BETHLEHEM PA 18015 USA

www.orasure.com P: 610-882-1820 F: 610-882-1830

Description:

OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.

Key Statistics

Overview:

Market Capitalization, $K 318,024
Enterprise Value, $K 27,614
Shares Outstanding, K 73,959
Annual Sales, $ 405,470 K
Annual Net Income, $ 53,660 K
Last Quarter Sales, $ 54,130 K
Last Quarter Net Income, $ -3,580 K
EBIT, $ 1,270 K
EBITDA, $ 22,210 K
60-Month Beta 0.09
% of Insider Shareholders 3.40%
% of Institutional Shareholders 93.50%
Float, K 71,444
% Float 96.60%
Short Volume Ratio 0.64

Growth:

1-Year Return -7.33%
3-Year Return -57.30%
5-Year Return -49.65%
5-Year Revenue Growth 123.10%
5-Year Earnings Growth 108.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 05/08/24
Next Earnings Date 08/01/24
Earnings Per Share ttm 0.42
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year -100.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 1.600 on 01/08/98
Dividend Payout Ratio 0.00%

OSUR Ratios

Ratio
Price/Earnings ttm 10.23
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 7.68%
Return-on-Assets % 6.83%
Profit Margin % 13.23%
Debt/Equity 0.00
Price/Sales 0.78
Price/Cash Flow 3.20
Price/Book 0.77
Book Value/Share 5.57
Interest Coverage -1.53

OSUR Dividends

Date Value
01/08/98 $1.6000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar